I
Inozyme Pharma D
D
INZY
5.40200
USD
-0.388
(-6.70%)
مغلق
حجم التداول
8,702
الربح لكل سهم
0
العائد الربحي
0
P/E
-3
حجم السوق
297,583,333
العنوان: Inozyme Pharma
القطاع: Healthcare
الصناعة: Biotechnology
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.